Cited by 159Nanoparticle-Based Drug DeliveryDrug Transport and Resistance MechanismsAdvanced Drug Delivery Systems

Polymeric Micelles for Multi-Drug Delivery in Cancer

Open access
Cho, Hyunah, Lai, Tsz Chung, Tomoda, Keishiro, Kwon, Glen S.·2015·AAPS PharmSciTech

Abstract

Drug combinations are common in cancer treatment and are rapidly evolving, moving beyond chemotherapy combinations to combinations of signal transduction inhibitors. For the delivery of drug combinations, i.e., multi-drug delivery, major considerations are synergy, dose regimen (concurrent versus sequential), pharmacokinetics, toxicity, and safety. In this contribution, we review recent research on polymeric micelles for multi-drug delivery in cancer. In concurrent drug delivery, polymeric micelles deliver multi-poorly water-soluble anticancer agents, satisfying strict requirements in solubility, stability, and safety. In sequential drug delivery, polymeric micelles participate in pretreatment strategies that "prime" solid tumors and enhance the penetration of secondarily administered anticancer agent or nanocarrier. The improved delivery of multiple poorly water-soluble anticancer agents by polymeric micelles via concurrent or sequential regimens offers novel and interesting strategies for drug combinations in cancer treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1208/s12249-014-0251-3

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. H e p p n e r G H . Tu m o r h e t e r o g e n e i t y. C a n c e r R e s . 1984;44(6):2259-65.
  2. Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensi- tivity. Lancet. 1995;345:1312-3.
  3. Lancet JE, Cortes JE, Hogge DE, Tallman MS, Kovacsovics TJ, Damon LE, et al. Phase II, multicenter, randomized, open label trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus cytarabine and daunorubicin in patients with untreated AML 60-75 years of age. Blood. 2014;123:3239-46.
  4. Chitkara D, Singh S, Kumar V, Danquah M, Behrman SW, Kumar N, et al. Micellar delivery of cyclopamine and gefi- t i n i b f o r t r e a t i n g p a n a r. M o l P h a r m . 2012;9:2350-7.

Cited by

Sorted by citations

Authors
Cho, H., Lai, T. C., Tomoda, K., & Kwon, G. S.
Affiliations
University of Wisconsin–Madison (US)
Corresponding author
Cho, Hyunah
Venue
AAPS PharmSciTech
Published
2014-12-11
Volume
16
Issue
1
Pages
10-20
ISSN
1530-9932 (ISSN-L)
OpenAlex
W2081911649
Cited by
159
References
71
Citations by year
2026: 7 · 2025: 11 · 2024: 10 · 2023: 16 · 2022: 13 · 2021: 28 · 2020: 22 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 6
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • AAPS PharmSciTech (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Research Foundation
  • National Research Foundation of Korea
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
polymeric micelles, multidrug delivery, cancer chemotherapy, combination therapy, signal transduction inhibitors, sequential drug delivery, drug synergy, pharmacokinetics, nanocarriers
MeSH terms
Animals, Antineoplastic Combined Chemotherapy Protocols, Diffusion, Drug Compounding, Humans, Micelles, Neoplasms, Particle Size, Polymers, Nanocapsules

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review